SCHEMBL3881350

SCHEMBL3881350

Cc1cc(O)c2oc3ccccc3c2c1N

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 5/20 0.48
KDM5A P29375 1/20 0.46
KDM4E B2RXH2 4/20 0.42
HSD17B10 Q99714 4/20 0.42
GAA P10253 3/20 0.42
HPGD P15428 3/20 0.42
MEN1 O00255 2/20 0.42
CYP3A4 P08684 2/20 0.42
MAPT P10636 2/20 0.42
PKM P14618 2/20 0.42
RECQL P46063 2/20 0.42
KMT2A Q03164 2/20 0.42
ALPI P09923 1/20 0.42
CASP3 P42574 1/20 0.42
BLM P54132 1/20 0.42
CASP7 P55210 1/20 0.42
CASP6 P55212 1/20 0.42
MCL1 Q07820 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
ESR2 Q92731 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3880857 0.88 MAOA (0.51) MAOAKDM5AKDM4EHSD17B10GAA
SCHEMBL3882623 0.84 NQO1 (0.43) MAOAKDM4EHSD17B10GAAHPGD
SCHEMBL3873224 0.78 NQO1 (0.43) MAOAKDM4EHSD17B10GAAHPGD
SCHEMBL3874492 0.76 PKM (0.54) MAOAKDM5AKDM4EHSD17B10GAA
SCHEMBL3874836 0.76 KDM4E (0.47) MAOAKDM4EHSD17B10GAAHPGD
SCHEMBL3882591 0.76 RECQL (0.50) MAOAKDM4EHSD17B10GAAHPGD
SCHEMBL3878151 0.76 KDM4E (0.42) MAOAKDM4EHSD17B10GAAHPGD
SCHEMBL3879211 0.75 PKM (0.53) MAOAKDM5AKDM4EHSD17B10GAA
SCHEMBL26450498 0.75 CDC14B (0.44) MAOAKDM5AKDM4EHSD17B10GAA
SCHEMBL3875285 0.74 PRKDC (0.38) MAOAKDM4EHSD17B10GAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080098535-A1 Keratin Dyeing Compounds, Keratin Dyeing Compositions Containing Them, And Use Thereof GLENN ROBERT W JR 2008-05-01 US claimed
US-20050217038-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof PROCTER & GAMBLE COMPANY, THE 2005-10-06 US claimed
US-7491245-B2 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2009-02-17 US disclosed
US-20080098535-A1 Keratin Dyeing Compounds, Keratin Dyeing Compositions Containing Them, And Use Thereof GLENN ROBERT W JR 2008-05-01 US disclosed
US-7331997-B2 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2008-02-19 US disclosed
EP-1735059-A2 KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF The Procter and Gamble Company (US) 2006-12-27 EP disclosed
WO-2005099656-A2 KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF THE PROCTER & GAMBLE COMPANY (US) 2005-10-27 WO disclosed
US-20050217038-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof PROCTER & GAMBLE COMPANY, THE 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050217038-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof KRT18, CKMT1A; CKMT1B, TUBB6 MAOA 500/4885KDM5A 259/4885KDM4E 1549/4885
US-20080098535-A1 Keratin Dyeing Compounds, Keratin Dyeing Compositions Containing Them, And Use Thereof KRT18, CKMT1A; CKMT1B, TUBB6 MAOA 500/4885KDM5A 259/4885KDM4E 1549/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.